These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 23657563

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway.
    Dai Y, Dai D, Wang X, Ding Z, Mehta JL.
    Cardiovasc Drugs Ther; 2014 Oct; 28(5):425-32. PubMed ID: 25022544
    [Abstract] [Full Text] [Related]

  • 23. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS.
    Bao MH, Zhang YW, Lou XY, Xiao Y, Cheng Y, Zhou HH.
    Can J Physiol Pharmacol; 2014 Apr; 92(4):299-306. PubMed ID: 24708212
    [Abstract] [Full Text] [Related]

  • 24. Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells.
    Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S.
    Horm Metab Res; 2011 Sep; 43(10):731-4. PubMed ID: 21932180
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis.
    Tashiro Y, Sato K, Watanabe T, Nohtomi K, Terasaki M, Nagashima M, Hirano T.
    Peptides; 2014 Apr; 54():19-26. PubMed ID: 24418070
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H, Hartmann B, Holst JJ, Viby NE, Hansen LS, Rosenkilde MM, Hare KJ, Poulsen SS.
    Regul Pept; 2012 Nov 10; 179(1-3):91-100. PubMed ID: 22989472
    [Abstract] [Full Text] [Related]

  • 30. Angiostatin prevents IL-1β-induced down-regulation of eNOS expression by inhibiting the NF-κB cascade.
    Kawasaki Y, Yokobayashi E, Sakamoto K, Tenma E, Takaki H, Chiba Y, Otashiro T, Ishihara M, Yonezawa S, Sugiyama A, Natori Y.
    J Pharmacol Sci; 2015 Nov 10; 129(3):200-4. PubMed ID: 26603529
    [Abstract] [Full Text] [Related]

  • 31. Nicorandil attenuates cyclic strain-induced endothelin-1 expression via the induction of activating transcription factor 3 in human umbilical vein endothelial cells.
    Chao HH, Hong HJ, Sung LC, Chen JJ, Cheng TH, Liu JC.
    Eur J Pharmacol; 2011 Sep 30; 667(1-3):292-7. PubMed ID: 21645504
    [Abstract] [Full Text] [Related]

  • 32. Positive and negative regulation of insulin action by genistein in the endothelium.
    Gao X, Liu K, Huang F, Zhang D, Guo X, Wang M, Liu B.
    J Nutr Biochem; 2013 Jan 30; 24(1):222-30. PubMed ID: 22901685
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.
    Kushima H, Mori Y, Koshibu M, Hiromura M, Kohashi K, Terasaki M, Fukui T, Hirano T.
    Cardiovasc Diabetol; 2017 Oct 02; 16(1):122. PubMed ID: 28969637
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.